<i>In vivo</i> evaluation of intestinal human CYP3A inhibition by macrolide antibiotics in CYP3A-humanised mice
<i>In vivo</i> evaluation of intestinal human CYP3A inhibition by macrolide antibiotics in CYP3A-humanised mice
复制标题
<i>体内评估大环内酯类抗生素对 CYP3A 人源化小鼠肠道人 CYP3A 的抑制作用
DOI:
10.1080/00498254.2021.1921314
复制
发表时间:
2021
期刊:
影响因子:
1.8
通讯作者:
Kobayashi Kaoru
中科院分区:
文献类型:
--
作者:
Minegishi Genki;Kazuki Yasuhiro;Nitta Shin-Ichiro;Miyajima Atsushi;Akita Hidetaka;Kobayashi Kaoru
It is important to predict drug-drug interactionsviainhibition of intestinal cytochrome P450 3A (CYP3A) which is a determinant of bioavailability of orally administered CYP3A substrates. However, inhibitory effects of macrolide antibiotics on CYP3A-mediated metabolism are not entirely identical between humans and rodents.We investigated the effects of macrolide antibiotics, clarithromycin and erythromycin, onin vitroandin vivometabolism of triazolam, a CYP3A substrate, in CYP3A-humanised mice generated by using a mouse artificial chromosome vector carrying a humanCYP3Agene.Metabolic activities of triazolam were inhibited by macrolide antibiotics in liver and intestine microsomes of CYP3A-humanised mice.The area under the plasma concentration-time curve ratios of 4-hydroxytriazolam to triazolam after oral dosing of triazolam were significantly decreased by multiple administration of macrolide antibiotics. The plasma concentrations ratios of α-hydroxytriazolam and 4-hydroxytriazolam to triazolam in portal blood were significantly decreased by multiple administration of clarithromycin in CYP3A-humanised mice.These results suggest that intestinal CYP3A activity was inhibited by macrolide antibiotics in CYP3A-humanised micein vitroandin vivo. The plasma concentrations of triazolam and its metabolites in the portal blood of CYP3A-humanised mice would be useful for direct evaluation of intestinal CYP3A-mediated drug-drug interactions.